Christopher French - Goldman Sachs Head MD
| GSGI34 Stock | BRL 120.19 1.88 1.59% |
Insider
Christopher French is Head MD of The Goldman Sachs
| Age | 67 |
| Phone | 212-902-1000 |
| Web | https://www.goldmansachs.com |
Christopher French Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher French against Goldman Sachs stock is an integral part of due diligence when investing in Goldman Sachs. Christopher French insider activity provides valuable insight into whether Goldman Sachs is net buyers or sellers over its current business cycle. Note, Goldman Sachs insiders must abide by specific rules, including filing SEC forms every time they buy or sell Goldman Sachs'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher French over a month ago Acquisition by Christopher French of 315 shares of Shenandoah Telecommunicatio at 14.91 subject to Rule 16b-3 | ||
Christopher French over three months ago Acquisition by Christopher French of 11782 shares of Shenandoah Telecommunicatio subject to Rule 16b-3 | ||
Christopher French over six months ago Acquisition by Christopher French of 5000 shares of Shenandoah Telecommunicatio at 14.0199 subject to Rule 16b-3 | ||
Christopher French over six months ago Disposition of 15144 shares by Christopher French of Shenandoah Telecommunicatio subject to Rule 16b-3 |
Goldman Sachs Management Efficiency
Goldman Sachs' management efficiency ratios could be used to measure how well Goldman Sachs manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | INSIDER Age | ||
| Thomas Klaritch | Healthpeak Properties | 65 | |
| Maria Ligorio | Hospital Mater Dei | N/A | |
| Jeffrey Miller | Healthpeak Properties | 63 | |
| Ankit Patadia | Healthpeak Properties | N/A | |
| Peter Scott | Healthpeak Properties | 43 | |
| Scott Brinker | Healthpeak Properties | 46 | |
| Andrew CFA | Healthpeak Properties | N/A | |
| Adam Mabry | Healthpeak Properties | N/A | |
| Rafael Cordeiro | Hospital Mater Dei | N/A | |
| Henrique Silva | Hospital Mater Dei | N/A | |
| Marcia Geo | Hospital Mater Dei | N/A | |
| Shawn Johnston | Healthpeak Properties | 43 | |
| James Croy | Healthpeak Properties | N/A | |
| Lisa Alonso | Healthpeak Properties | 46 | |
Management Performance
| Return On Equity | 0.0989 | |||
| Return On Asset | 0.0078 |
Goldman Sachs Leadership Team
Elected by the shareholders, the Goldman Sachs' board of directors comprises two types of representatives: Goldman Sachs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Goldman. The board's role is to monitor Goldman Sachs' management team and ensure that shareholders' interests are well served. Goldman Sachs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Goldman Sachs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Waldron, President COO | ||
| Denis III, Chief Officer | ||
| Kathryn Ruemmler, Sec Officer | ||
| Christopher French, Head MD | ||
| F Mallmann, Chair Banking | ||
| Philip Berlinski, Global Treasurer | ||
| J Gardner, Director | ||
| Atte Lahtiranta, Partner Officer | ||
| Sheara Fredman, Controller Officer | ||
| David Solomon, President COO |
Goldman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Goldman Sachs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0989 | |||
| Return On Asset | 0.0078 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 946.33 B | |||
| Shares Outstanding | 10.11 B | |||
| Price To Earning | 22.60 X | |||
| Price To Book | 1.13 X | |||
| Price To Sales | 13.29 X | |||
| Revenue | 47.37 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Goldman Stock
Goldman Sachs financial ratios help investors to determine whether Goldman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldman with respect to the benefits of owning Goldman Sachs security.